Abstract
Precise editing of human genomes in pluripotent stem cells by homology-driven repair of targeted nuclease–induced cleavage has been hindered by the difficulty of isolating rare clones. We developed an efficient method to capture rare mutational events, enabling isolation of mutant lines with single-base substitutions without antibiotic selection. This method facilitates efficient induction or reversion of mutations associated with human disease in isogenic human induced pluripotent stem cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
da Cunha Santos, G., Shepherd, F.A. & Tsao, M.S. Annu. Rev. Pathol. 6, 49–69 (2011).
Moore, J.R., Leinwand, L. & Warshaw, D.M. Circ. Res. 111, 375–385 (2012).
Takahashi, K. et al. Cell 131, 861–872 (2007).
Yu, J. et al. Science 318, 1917–1920 (2007).
Gaj, T., Gersbach, C.A. & Barbas, C.F. III. Trends Biotechnol. 31, 397–405 (2013).
Fu, Y. et al. Nat. Biotechnol. 31, 822–826 (2013).
Gupta, A., Meng, X., Zhu, L.J., Lawson, N.D. & Wolfe, S.A. Nucleic Acids Res. 39, 381–392 (2011).
Hsu, P.D. et al. Nat. Biotechnol. 31, 827–832 (2013).
Pattanayak, V., Ramirez, C.L., Joung, J.K. & Liu, D.R. Nat. Methods 8, 765–770 (2011).
Ding, Q. et al. Cell Stem Cell 12, 238–251 (2013).
Chen, F. et al. Nat. Methods 8, 753–755 (2011).
Soldner, F. et al. Cell 146, 318–331 (2011).
Mali, P. et al. Nat. Biotechnol. 31, 833–838 (2013).
Ran, F.A. et al. Cell 154, 1380–1389 (2013).
McCormick, M. Methods Enzymol. 151, 445–449 (1987).
Hindson, B.J. et al. Anal. Chem. 83, 8604–8610 (2011).
Cong, L. et al. Science 339, 819–823 (2013).
Mali, P. et al. Science 339, 823–826 (2013).
Yusa, K. et al. Nature 478, 391–394 (2011).
Doyle, E.L. et al. Nucleic Acids Res. 40, W117–W122 (2012).
Sander, J.D. et al. Nucleic Acids Res. 38, W462–W468 (2010).
Sander, J.D., Zaback, P., Joung, J.K., Voytas, D.F. & Dobbs, D. Nucleic Acids Res. 35, W599–W605 (2007).
Cermak, T. et al. Nucleic Acids Res. 39, e82 (2011).
Bedell, V.M. et al. Nature 491, 114–118 (2012).
Christian, M.L. et al. PLoS ONE 7, e45383 (2012).
Cong, L., Zhou, R., Kuo, Y.C., Cunniff, M. & Zhang, F. Nature Commun. 3, 968 (2012).
Kreitzer, F.R. et al. Am. Journal Stem Cells 2, 119–131 (2013).
Okita, K. et al. Nat. Methods 8, 409–412 (2011).
Watanabe, K. et al. Nat. Biotechnol. 25, 681–686 (2007).
Grau, J., Boch, J. & Posch, S. Bioinformatics 29, 2931–2932 (2013).
Acknowledgements
We thank members of the Conklin laboratory for technical assistance and critical reading of the manuscript, B.G. Bruneau, D. Srivastava, S. Yamanaka, K. Tomoda, Y. Hayashi, K.E. Eilertson, B.S. Moriarity, D.A. Largaespada and W.A. Weiss for valuable discussions and advice, A.K. Holloway for generating the list of unique CRISPR target sites, K. Carver-Moore for her technical assistance in iPS cell culture on 96-well plates, M. Porteus and M. Rahdar (Stanford University) for providing us with the TALEN backbone plasmid MR015, and members of the Roddenberry Stem Cell Core at Gladstone Institutes for providing a stimulating environment. Y.M. is a recipient of a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad and the Uehara Memorial Foundation Research Fellowship. L.M.J. is supported by a postdoctoral fellowship, TG2-01160, from the California Institute of Regenerative Medicine. M.H. is supported by a postdoctoral fellowship, PF-13-295-01–TBG, from the American Cancer Society. B.R.C. received support from the US National Heart, Lung, and Blood Institute, National Institutes of Health, U01-HL100406, U01-GM09614, R01-HL108677, U01-HL098179 and R01-HL060664.
Author information
Authors and Affiliations
Contributions
Y.M. and B.R.C. conceived and designed the experiments. Y.M. and A.H.C. conducted most of the experiments. L.M.J. and J.Y. performed the BAG3 mutagenesis, and J.Y. constructed the PKP2 TALENs. M.H. designed and constructed the PHOX2B TALENs and helped with the Surveyor assays. T.D.N. helped to conceive ddPCR experiments and to construct TALENs. P.P.L. conducted immunofluorescence staining. Y.M., P.-L.S. and B.R.C. wrote the manuscript with support from all authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–10, and Supplementary Tables 1, 2, 4 and 5 (PDF 3062 kb)
Supplementary Table 3
On- and off-target sites for the PHOX2B and PRKAG2 TALENs predicted by TALENoffer (XLSX 59 kb)
Rights and permissions
About this article
Cite this article
Miyaoka, Y., Chan, A., Judge, L. et al. Isolation of single-base genome-edited human iPS cells without antibiotic selection. Nat Methods 11, 291–293 (2014). https://doi.org/10.1038/nmeth.2840
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nmeth.2840
This article is cited by
-
Validated assays for the quantification of C9orf72 human pathology
Scientific Reports (2024)
-
Functional analysis of a common BAG3 allele associated with protection from heart failure
Nature Cardiovascular Research (2023)
-
A CRISPR-engineered isogenic model of the 22q11.2 A-B syndromic deletion
Scientific Reports (2023)
-
Laser-Induced Axotomy of Human iPSC-Derived and Murine Primary Neurons Decreases Somatic Tau and AT8 Tau Phosphorylation: A Single-Cell Approach to Study Effects of Acute Axonal Damage
Cellular and Molecular Neurobiology (2023)
-
CRISPR Del/Rei: a simple, flexible, and efficient pipeline for scarless genome editing
Scientific Reports (2022)